The largest database of trusted experimental protocols

Stemdiff neural progenitor supplement a

Manufactured by STEMCELL
Sourced in Canada

STEMdiff™ Neural Progenitor Supplement A is a cell culture supplement designed to support the growth and maintenance of neural progenitor cells derived from human pluripotent stem cells.

Automatically generated - may contain errors

2 protocols using stemdiff neural progenitor supplement a

1

Differentiation of hiPSC-Derived Neural Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze the differentiation of human cells in direct contact with biomaterials, neural progenitor cells derived from human induced pluripotent stem cells (hiPSC-NPC) were used; these were cultured as previously described from the hiPSC line, 1-DL-01, from WiCell [104 (link)]. Experiments using hiPSC-NPC were conducted with the approval of the University of Victoria’s Human Ethics Committee under protocol number #12-187. Briefly, the cells were cultured in STEMdiff™ Neural progenitor medium (NPM) (05834, Stemcell Technologies, Vancouver, BC, Canada) containing 1X STEMdiff™ Neural Progenitor Supplement A (05836, Stemcell Technologies, Vancouver, BC, Canada), 1X STEMdiff™ Neural Progenitor Supplement B (05837, Stemcell Technologies, Vancouver, BC, Canada), and 1% penicillin-streptomycin (P4333, Sigma Aldrich, St. Louis, MO, USA). These medium supplements were used to promote the efficient conversion of hiPSC to CNS-type NPCs and inhibit the unwanted differentiation of non-CNS-type cells. The cultured hiPSC-NPC were maintained at 37 °C with 5% CO2, and media changes were performed daily.
+ Open protocol
+ Expand
2

Differentiation of iPSCs into Neural Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HDF51i-509iPSCs were differentiated into NPCs as described previously (Murphy et al. 2017 (link)). NPCs were then maintained in STEMdiff™ Neural Progenitor Medium (STEMCELL Technologies) supplemented with 1 × STEMdiff neural progenitor supplement A (STEMCELL Technologies) and 1 × STEMdiff neural progenitor supplement B (STEMCELL Technologies) at 37 °C and 5% CO2. Neural differentiation was initiated by replacing 50% v/v of the culture medium every 2–3 days with BrainPhysTM neural medium (STEMCELL Technologies) supplemented with 2% v/v Neurocult™ SM1 Neuronal Supplement (STEMCELL Technologies), 1% v/v N2 Supplement-A (STEMCELL Technologies), 20 ng/mL human recombinant brain-derived neurotrophic factor, 20 ng/mL human recombinant glial cell line–derived neurotrophic factor (Peprotech), 1 mM dibutyryl cyclic-AMP sodium salt (Sigma-Aldrich), and 200 nM ascorbic acid (STEMCELL Technologies), making complete BrainPhys™ neural medium (Sundaramoorthy et al. 2020a ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!